Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBBY AYOUB

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1396958237
CMS profile
108533
Location
HUNTINGTON BEACH, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$2,739.60

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,696.65 97
Education $42.95 1

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBBY AYOUB

NPI 1396958237 · CMS profile ID 108533

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

HUNTINGTON BEACH, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396958237?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBBY AYOUB, NPI 1396958237, CMS profile ID 108533. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396958237?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ROBBY AYOUB, NPI 1396958237, CMS profile ID 108533. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396958237?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ROBBY AYOUB, NPI 1396958237, CMS profile ID 108533, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1396958237?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $2,739.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–98 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Regeneron Healthcare Solutions, Inc. $33.9907/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114002661 CMS
Novartis Pharmaceuticals Corporation $28.9907/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086702663 CMS
AstraZeneca Pharmaceuticals LP $23.7606/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104689300 CMS
GlaxoSmithKline, LLC. $31.2506/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116396686 CMS
Mylan Specialty L.P. $29.8206/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147287336 CMS
Amgen Inc. $20.8906/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115433098 CMS
JAZZ PHARMACEUTICALS INC. $34.5906/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150213029 CMS
GlaxoSmithKline, LLC. $30.9306/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116219505 CMS
GlaxoSmithKline, LLC. $24.9206/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116240080 CMS
HARMONY BIOSCIENCES LLC $32.8706/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126057951 CMS
Optinose US, Inc. $20.4605/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142171416 CMS
PFIZER INC. $25.1005/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131509212 CMS
Regeneron Healthcare Solutions, Inc. $35.7205/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114002659 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.0105/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117995106 CMS
REVANCE THERAPEUTICS, INC. $15.0105/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147912040 CMS
GENZYME CORPORATION $139.1105/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139767746 CMS
Vifor Pharma, Inc. $17.4505/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124038110 CMS
AstraZeneca Pharmaceuticals LP $23.0904/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104530106 CMS
AstraZeneca Pharmaceuticals LP $19.1304/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105449829 CMS
Mylan Specialty L.P. $24.7004/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147352245 CMS
GlaxoSmithKline, LLC. $24.7504/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116520654 CMS
GENZYME CORPORATION $75.6804/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139767742 CMS
GlaxoSmithKline, LLC. $34.9304/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116355995 CMS
Avadel CNS Pharmaceuticals, LLC $28.6504/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1123379017 CMS
AstraZeneca Pharmaceuticals LP $19.2804/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105547937 CMS
JAZZ PHARMACEUTICALS INC. $22.5003/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150213033 CMS
Regeneron Healthcare Solutions, Inc. $32.6903/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114002657 CMS
GlaxoSmithKline, LLC. $26.3703/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116209135 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.8503/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117995100 CMS
HARMONY BIOSCIENCES LLC $47.3003/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126057949 CMS
Philips North America LLC $16.7803/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146867101 CMS
GlaxoSmithKline, LLC. $30.0703/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116223444 CMS
REVANCE THERAPEUTICS, INC. $15.5802/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147912038 CMS
Sumitomo Pharma America, Inc. $18.6302/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148823199 CMS
Mylan Specialty L.P. $28.5302/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147330089 CMS
GlaxoSmithKline, LLC. $26.3702/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116440557 CMS
AstraZeneca Pharmaceuticals LP $13.2502/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104557924 CMS
AstraZeneca Pharmaceuticals LP $64.8902/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105516593 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.5002/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117995098 CMS
PFIZER INC. $24.9602/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131443929 CMS
Amgen Inc. $17.5102/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115433093 CMS
Regeneron Healthcare Solutions, Inc. $39.6702/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114002655 CMS
GlaxoSmithKline, LLC. $30.7201/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115909691 CMS
AstraZeneca Pharmaceuticals LP $14.4701/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104772720 CMS
Regeneron Healthcare Solutions, Inc. $31.6501/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114002653 CMS
Grifols USA, LLC $30.1101/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124711728 CMS
JAZZ PHARMACEUTICALS INC. $23.0901/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150213027 CMS
Mylan Specialty L.P. $20.4201/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147312179 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,689.86 93
PY2020 $1,114.10 54
PY2021 $1,052.90 44
PY2022 $2,319.19 80
PY2023 $2,990.15 106
PY2024 $2,739.60 98
PY2025 $3,981.23 168

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $25,164.46 22
PY2024 Principal investigator $62,053.29 55
PY2023 Principal investigator $61,292.45 21
PY2022 Principal investigator $46,508.42 10
PY2021 Principal investigator $19,921.00 9
PY2020 Principal investigator $11,500.00 1
PY2019 Principal investigator $79,086.52 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $9,986.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744279
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,027.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744281
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $344.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744283
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $200.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744285
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,500.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744287
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $114.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744289
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,895.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744291
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $600.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744293
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,479.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744295
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $98.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744297
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $154.00 07/23/2025 Non-covered Recipient Entity
Southern California Medical Group
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744299
Principal investigator 1 Chiesi USA, Inc. $240.00 06/12/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP INC
A 12 week, randomized, double-blind, multicenter, active controlled, 2-arm parallel group study testing the superiority of CHF 1535 pMDI 800/24?g total daily dose (fixed combination of extrafine beclomethasone dipropionate plus formoterol fumarate) compared to CHF 718 pMDI 800?g total daily dose (extrafine beclomethasone dipropionate) in adults with asthma on medium or high-dose inhaled corticosteroid. No dispute reported 06/30/2026 1234402990
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $0.96 06/11/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744263
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $6.72 06/11/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744265
Principal investigator 1 GlaxoSmithKline, LLC. $2,912.08 04/24/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A PROSPECTIVE, REAL-WORLD, INTERVENTIONAL STUDY TO EVALUATE THE EFFECT No dispute reported 06/30/2026 1192121670
Principal investigator 1 GlaxoSmithKline, LLC. $578.70 04/04/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192121654
Principal investigator 1 GlaxoSmithKline, LLC. $1,860.00 03/07/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192121663
Principal investigator 1 GlaxoSmithKline, LLC. $982.00 02/07/2025 Non-covered Recipient Entity
SOUTHERN CALIFORNIA MEDICAL GROUP
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192121659
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $42.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744255
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $35.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744257
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $55.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744259
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $55.00 01/31/2025 Non-covered Recipient Entity
So Cal Clinical Research
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233744261